Analysis of a population-based Pneumocystis carini pneumonia index as an outcome measure of access and quality of care for the treatment of HIV disease

被引:7
作者
Arno, PS [1 ]
Gourevitch, MN [1 ]
Drucker, E [1 ]
Fang, J [1 ]
Goldberg, C [1 ]
Memmott, M [1 ]
Bonuck, K [1 ]
Deb, N [1 ]
Schoenbaum, E [1 ]
机构
[1] Albert Einstein Coll Med, Dept Epidemiol & Social Med, Montefiore Med Ctr, Bronx, NY 10467 USA
关键词
D O I
10.2105/AJPH.92.3.395
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives. A population-based Pneumocystis carinii pneumonia (PCP) Index was developed in New York City to identify geographic areas and subpopulations at increased risk for PCP. Methods. A zip code-level PCP Index was created from AIDS surveillance and hospital discharge records and defined as (number of PCP-related hospitalizations)/(number of persons living with AIDS). Results, In 1997, there were 2262 hospitalizations for PCP among 39 740 persons living with AIDS in New York City (PCP Index=.05691). PCP Index values varied widely across neighborhoods with high AIDS prevalence (West Village=.02532 vs Central Harlem=.08696). Some neighborhoods with moderate AIDS prevalence had strikingly high rates (Staten Island=.14035; northern Manhattan=.08756). Conclusions. The PCP Index highlights communities in particular need of public health interventions to improve HIV-related service delivery.
引用
收藏
页码:395 / 398
页数:4
相关论文
共 17 条
[1]  
[Anonymous], 1992, MMWR Recomm Rep, V41, P1
[2]  
[Anonymous], 1999, MMWR Recomm Rep, V48, P1
[3]  
[Anonymous], 1997, MMWR Recomm Rep, V46, P1
[4]  
[Anonymous], 1995, Clin Infect Dis, V21 Suppl 1, pS32
[5]   US hospital care for HIV-infected persons and the role of public, private, and veterans administration hospitals [J].
Bennett, CL ;
Curtis, JR ;
Achenbach, C ;
Arno, P ;
Bennett, R ;
Fahs, MC ;
Horner, RD ;
ShawTaylor, Y ;
Andrulis, D .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 13 (05) :416-421
[6]  
Centers for Disease Control (CDC), 1989, MMWR Suppl, V38, P1
[7]   Impact of opportunistic disease on survival in patients with HIV infection [J].
Chaisson, RE ;
Gallant, JE ;
Keruly, JC ;
Moore, RD .
AIDS, 1998, 12 (01) :29-33
[8]   The cost-effectiveness of preventing AIDS-related opportunistic infections [J].
Freedberg, KA ;
Scharfstein, JA ;
Seage, GR ;
Losina, E ;
Weinstein, MC ;
Craven, DE ;
Paltiel, AD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (02) :130-136
[9]  
HUANG L, 1998, 5 C RETR OPP INF FEB
[10]   Drug therapy: Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection. [J].
Kovacs, JA ;
Masur, H .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (19) :1416-1429